Rachel Moate

Treatment of atopic dermatitis with tralokinumab, an anti–IL-13 mAb

Andreas Wollenberg, Michael Howell, Emma Guttman‐Yassky et al. · Journal of Allergy and Clinical Immunology · 2018 · 421 citations

Medicine, Dermatology, Immunology +17

A CD40L-targeting protein reduces autoantibodies and improves disease activity in patients with autoimmunity

Jodi L. Karnell, M. Albulescu, Stacey Drabic et al. · Science Translational Medicine · 2019 · 98 citations

Life Sciences, Immunology, Molecular Biology +15

A phase 2a trial of the IL-33 monoclonal antibody tozorakimab in patients with COPD: FRONTIER-4

Dave Singh, Patricia Guller, Fred Reid et al. · European Respiratory Journal · 2025 · 48 citations

Medicine, Immunology, Pharmacotherapy +17

A Randomized Phase I Study of the Anti‐Interleukin‐33 Antibody Tozorakimab in Healthy Adults and Patients With Chronic Obstructive Pulmonary Disease

Fred Reid, Dave Singh, Muna Albayaty et al. · Clinical Pharmacology & Therapeutics · 2023 · 42 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +10

Efficacy, safety, and tolerability of a triple reuptake inhibitor GSK372475 in the treatment of patients with major depressive disorder: two randomized, placebo- and active-controlled clinical trials

Susan M. Learned, Ole Graff, Suraja M. Roychowdhury et al. · Journal of Psychopharmacology · 2011 · 24 citations

Medicine, Pharmacology, Psychiatry +15